Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortUltra-long-acting basal insulin lasting over 42 hours.Once-daily long-acting background insulin.
Body systemDiabetes & WeightDiabetes & Weight
Drug classInsulinsInsulins
SupplyPrescription onlyPrescription onlyWHO essential medicine
Main usesType 1 diabetes, Type 2 diabetesType 1 diabetes (basal), Type 2 diabetes
How it worksA slow, steady background insulin that lasts more than a day.Releases slowly from under the skin to keep blood sugar steady all day and night.
Starts workingSeveral hours1–2 hours, no peak
Half-lifeAbout 25 hours (action over 42 hours)Duration about 24 hours
Typical adult doseType 2: 10 units once a day to start (or 0.1–0.2 units/kg), adjusted by blood sugars; type 1 doses are individual.Individual — commonly started at 10 units (or 0.1–0.2 units/kg) once a day and adjusted to fasting glucose.
FormsPen injection, VialPen injection, Vial, Cartridge
Common side effectsLow blood sugar, Injection site reactions, Weight gainLow blood sugar, Weight gain, Injection-site lumps
Serious side effectsSevere hypoglycaemia, Low potassium, Lipodystrophy at injection sitesSevere hypoglycaemia, Low potassium (rare)
Don't take ifLow blood sugar episodes in progress; Allergy to insulin or ingredients—
AlcoholBest to limit. Alcohol, especially without food, can cause serious low blood sugar.—
PregnancyGenerally considered safeInsulin is the treatment of choice in pregnancy; doses change through each trimester.Generally considered safeInsulin is the mainstay of diabetes treatment in pregnancy.
BreastfeedingGenerally considered safeInsulin is safe while breastfeeding; doses may need reducing.—
In use since—2000
Brand namesUnited States: TresibaUnited Kingdom: TresibaIndia: TresibaUnited States: Lantus, Toujeo, Basaglar, SemgleeUnited Kingdom: Lantus, Toujeo, AbasaglarIndia: Lantus, Basalog, Glaritus
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H—
ATC codeA10AE06A10AE04

Taken together

  • MinorInsulin degludec + Insulin glargine: More risk of low blood sugar

    Both medicines lower blood sugar; combinations are common but hypos become more likely.

Open in the interaction checker